| Dr Maryam Saheb-al-zamani, MD | |
|
510 20th St South, Birmingham, AL 35294-3411 | |
| (205) 934-2307 | |
| Not Available |
| Full Name | Dr Maryam Saheb-al-zamani |
|---|---|
| Gender | Female |
| Speciality | Plastic Surgery |
| Location | 510 20th St South, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205312105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | MD.37202 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maryam Saheb-al-zamani, MD 103 John Whitaker Building 500 22nd Street South, Birmingham, AL 35294-0500 Ph: (205) 934-2307 | Dr Maryam Saheb-al-zamani, MD 510 20th St South, Birmingham, AL 35294-3411 Ph: (205) 934-2307 |
News Archive
The first Irukandji jellyfish to be bred in captivity have been born in Townsville, Australia. ‘Irukandji syndrome' is a painful and debilitating set of symptoms that has caused the deaths of at least two people on the Great Barrier Reef. Up to seven species of jellyfish found in northern Australian waters are thought to be responsible for the syndrome, but only one, Carukia barnesi , is a proven culprit.
Accessible and affordable healthcare is one of the topics of Healthcare Automation and Digitalization Congress.
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that its shareholders voted at a Special Meeting of Shareholders to approve the previously-announced acquisition of all outstanding shares of common stock of Millipore by Merck KGaA of Germany, the global pharmaceutical and chemical company.
OriGene Technologies, Inc. today announced the acquisition of Marligen Biosciences, Inc., a provider of cutting-edge multiplex assays for the Luminex xMAP(R) platform for protein and gene expression profiling assays and testing services, and DNA and RNA purification kits.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Piperacillin and Tazobactam for Injection, the number one prescribed intravenous antibiotic in the U.S. APP will launch the product immediately.
› Verified 8 days ago
Kamil Marcin Pietrasik, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-731-9701 | |
Dr. Christopher Jon Schaffer, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 140 Village St Ste 100, Birmingham, AL 35242 Phone: 205-980-1744 Fax: 205-980-1334 | |
Dr. Michael S Clinton, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7191 Cahaba Valley Rd, Ste 200, Birmingham, AL 35242 Phone: 205-408-9787 Fax: 205-408-3993 | |
James Stephen Gunn, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 140 Village St Ste 100, Birmingham, AL 35242 Phone: 205-980-1744 Fax: 205-980-1334 | |
Guillermo Oswaldo Ramos-gallardo, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-731-9701 Fax: 205-297-9411 | |
Dr. William B Nickell, M,D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 Cahaba Park Cir, Birmingham, AL 35242 Phone: 295-980-9393 Fax: 205-980-4494 |